In late 2020, BD invested $1.2 billion for a four-year plan to boost its prefillable syringe manufacturing efforts because of mRNA innovations in vaccine technology.
About 70 percent of the top 100 pharmaceutical companies buy prefillable syringes from BD, and the new product will help finish-and-fill manufacturing efforts, according to the company.
Eric Borin, the president of BD’s pharmaceutical sector, said the product could help with dose-sparing, a new supply strategy used for monkeypox vaccines in which doses are split into fifths and the vaccines are administered closer to the top skin layer.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
